NJ State Employees Deferred Compensation Plan’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-17,500	Closed	-$264K	–	389
2016 Q4	$264K	Hold	17,500	–	–	0.05%	327
2016 Q3	$267K	Hold	17,500	–	–	0.06%	320
2016 Q2	$679K	Hold	17,500	–	–	0.14%	224
2016 Q1	$603K	Hold	17,500	–	–	0.13%	244
2015 Q4	$941K	Hold	17,500	–	–	0.19%	176
2015 Q3	$701K	Buy	+17,500	New	+$571K	0.15%	219

Other funds holding ITCI

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return